
zzso zzso agents zzso are an exciting new group of targeted therapies under active clinical research in many solid tumors, in particular, lung zzso zzso zzso are the focus of current clinical research, and consist of the zzso and the zzso zzso zzso of zzso zzso are characterized by zzso zzso and generally zzso side effects including zzso zzso and zzso tumor pain, hypertension, and zzso zzso agents can also cause infusion site pain, visual zzso zzso zzso and symptoms consistent with an acute release of zzso zzso agents can result in cardiac zzso abdominal pain, zzso abnormalities and zzso zzso and acute zzso zzso Clinical trials investigating zzso in combination with traditional chemotherapy have also shown the potential for significant zzso and adverse toxicity zzso Further research will need to focus on zzso and zzso parameters to zzso dosing schedules, determine effective combinations with chemotherapy, and minimize zzso associated with zzso 

